Evidence map›Paper›PMID 41660632›Full record

ArticleResearch (Washington, D.C.)2026

Dual Sensitization Enables Synergistic Photodynamic Therapy and Radiotherapy for Breast Cancer.

Yingying Zhang, Shaoqing Chen, Chun Liu, Pengyin Li, Yutao Zhang, Ziman Li, Xinye Ni

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yingying ZhangThe Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University; Jiangsu Province Engineering Research Center of Medical Physics; Medical Physics Research Center, Nanjing Medical University; Key Laboratory of Medical Physics in Changzhou, Jiangsu, Changzhou 213003, China.
Shaoqing ChenThe Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University; Jiangsu Province Engineering Research Center of Medical Physics; Medical Physics Research Center, Nanjing Medical University; Key Laboratory of Medical Physics in Changzhou, Jiangsu, Changzhou 213003, China.
Chun LiuThe Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University; Jiangsu Province Engineering Research Center of Medical Physics; Medical Physics Research Center, Nanjing Medical University; Key Laboratory of Medical Physics in Changzhou, Jiangsu, Changzhou 213003, China.
Pengyin LiSchool of Pharmacy, Changzhou University, Jiangsu, Changzhou, 213164, China.
Yutao ZhangThe Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University; Jiangsu Province Engineering Research Center of Medical Physics; Medical Physics Research Center, Nanjing Medical University; Key Laboratory of Medical Physics in Changzhou, Jiangsu, Changzhou 213003, China.
Ziman LiSchool of Pharmacy, Changzhou University, Jiangsu, Changzhou, 213164, China.
Xinye NiThe Second People's Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University; Jiangsu Province Engineering Research Center of Medical Physics; Medical Physics Research Center, Nanjing Medical University; Key Laboratory of Medical Physics in Changzhou, Jiangsu, Changzhou 213003, China.ORCID https://orcid.org/0000-0002-2402-9719

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy (RT) and photodynamic therapy (PDT) for breast cancer are limited by tumor hypoxia and suboptimal photosensitizer performance. We developed folate-modified copper-doped carbon dots and loaded them with 5-aminolevulinic acid (ALA) to yield FCA, a nanoplatform that executes cascade nanozyme activities to remodel the tumor microenvironment: decomposing H

Identifiers

PMID41660632
PMCPMC12876564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.